Affordable Access

Alzheimer’s Disease: New Therapies And the Role of Biomarkers

Authors
Publisher
BioCommunications LLC
Publication Date
Keywords
  • Feature Articles
  • Clinical
Disciplines
  • Medicine

Abstract

Biomarkers have shown promise for identifying people at high risk for Alzheimer’s disease. Therapies that address presymptomatic disease are already in development, and MCOs should start thinking about coverage for them.

There are no comments yet on this publication. Be the first to share your thoughts.